Experiment 68547
Worktypes
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | ORAL |
| Organism | Empty organism |
| Citation | MONTORSI,F: STRAMBI,LF: GUAZZONI,G: GALLI,L: BARBIERI,L: RIGATTI,P: PIZZINI,G: MIANI,A:. (1994). EFFECT OF YOHIMBINE-TRAZODONE ON PSYCHOGENIC IMPOTENCE: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY.. 44(5) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE AIM OF THIS STUDY WAS TO DETERMINE THE EFFECTIVENESS AND SAFETY OF YOHIMBINE AND TRAZODONE USED TOGETHER FOR THE TREATMENT OF PURE PSYCHOGENIC IMPOTENCE. SIXTY-THREE PATIENTS WHO HAD PSYCHOGENIC IMPOTENCE IDAGNOSED ON THE BASIS OF SEXUAL HISTORY, RESULTS OF PHYSICAL EXAMINATION, LABORATORY ANALYSIS , POLYSOMNOGRAPHIC RECORDING OF NOCTURNAL ERECTIONS, AND DYNAMIC COLOR DOPPLER SONOGRAPHY OF THE CAVERNOSAL ARTERIES WERE ENTERED INTO A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARTIAL CROSSOVER STUDY COMPARING PLACEBO WITH YOHIMINE (15 MG PER DAYORALLY) AND TRAZODONE (50 MG PER DAY ORALLY) USED TOGETHER. THE COMBINATION OF YOHIMBINE AND TRAZODONE IS A SAFE AND EFFECTIVE FIRST-LINE TREATMENT FOR PSYCHOGENIC IMPOTENCE. |
| Dose amount | 15.0 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | DAY |
| Dose expression | DOSE |
| Gender | MALE |